Armistice Capital’s Sanofi SNY Stock Holding History

Armistice Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.4M	Buy	1,064,000 +764,000	+255%	+$34.1M	0.56%	27
2026 Q1	$14.5M	Sell	300,000 -376,000	-56%	-$17.5M	0.26%	71
2025 Q4	$32.8M	Buy	676,000 +64,000	+10%	+$3.17M	0.39%	45
2025 Q3	$28.9M	Buy	+612,000	New	+$29.5M	0.43%	36
2025 Q2	–	Sell	-524,000	Closed	-$29.1M	–	263
2025 Q1	$29.1M	Sell	524,000 -724,000	-58%	-$39.2M	0.44%	45
2024 Q4	$60.2M	Buy	1,248,000 +668,000	+115%	+$34M	0.82%	25
2024 Q3	$33.4M	Sell	580,000 -920,000	-61%	-$49.7M	0.53%	35
2024 Q2	$72.8M	Buy	1,500,000 +202,000	+16%	+$9.74M	0.92%	12
2024 Q1	$63.1M	Buy	1,298,000 +262,000	+25%	+$12.8M	0.84%	12
2023 Q4	$51.5M	Buy	+1,036,000	New	+$50.7M	0.7%	27
2016 Q3	–	Sell	-138,000	Closed	-$5.78M	–	53
2016 Q2	$5.78M	Buy	+138,000	New	+$5.66M	2.2%	18

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Armistice Capital's SNY Position: Q2 2026 in Review

Armistice Capital increased its Sanofi (SNY) stake by 255% in Q2 2026, buying an estimated $34.1M and bringing the position to 1,064,000 shares worth $45.4M. The position accounts for 0.56% of the portfolio, ranked #27.

Armistice Capital first reported a position in SNY in Q2 2016 and has held it in 11 quarters since. The position peaked at $72.8M in Q2 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Armistice Capital held 1,064,000 shares of Sanofi worth $45.4M as of Q2 2026.
Armistice Capital bought 764,000 Sanofi shares in Q2 2026, an estimated $34.1M.
Sanofi made up 0.56% of Armistice Capital's portfolio in Q2 2026, its #27 holding.
Armistice Capital first reported a position in Sanofi in Q2 2016 and has held it in 11 quarters since.
Armistice Capital's Sanofi position peaked at $72.8M in Q2 2024.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.